Kaisa Health Group Holdings Limited (HKG:0876)
Hong Kong · Delayed Price · Currency is HKD 1.920
-0.030 (-1.54%)
Sep 11, 2026, 11:06 AM HKT
HKG:0876 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 85.5 | 139.11 | 185.36 | 185.88 | 191.5 | 209.63 | |
Revenue Growth | -48.62% | -24.95% | -0.28% | -2.93% | -8.65% | 14.04% |
Cost of Revenue | 67.33 | 88.47 | 103.5 | 104.81 | 108.93 | 112.21 |
Gross Profit | 18.18 | 50.64 | 81.86 | 81.07 | 82.57 | 97.42 |
Selling, General & Admin | 85.46 | 86.27 | 93.59 | 107.4 | 132.54 | 157.3 |
Research & Development | 22.25 | 16.91 | 12.48 | 16.84 | - | - |
Other Operating Expenses | - | - | - | - | 17.43 | 17.22 |
Operating Expenses | 104.6 | 106.04 | 105.08 | 124.82 | 154.8 | 175.34 |
Operating Income | -86.42 | -55.4 | -23.23 | -43.74 | -72.24 | -77.93 |
Interest Expense | -0.25 | -0.59 | -0.78 | -3.67 | -7.73 | -8.18 |
Interest & Investment Income | 8.27 | 1.03 | 2.51 | 3.23 | 4.14 | 1.32 |
Currency Exchange Gain (Loss) | -0.6 | -0.99 | 0.35 | 0.11 | 0.78 | -1.81 |
Other Non Operating Income (Expenses) | -11.37 | -1.37 | -20.07 | 0.6 | -13.04 | 4.81 |
EBT Excluding Unusual Items | -90.37 | -57.31 | -41.21 | -43.48 | -88.08 | -81.79 |
Gain (Loss) on Sale of Investments | -13.36 | 10.56 | -9.77 | -21.3 | -12.07 | 66.02 |
Gain (Loss) on Sale of Assets | -0.81 | -0.81 | 0.19 | 68.96 | -0.01 | -2.21 |
Asset Writedown | - | - | - | - | -73.36 | - |
Other Unusual Items | 0.62 | 0.62 | 2.11 | 1.86 | 2.56 | 29.19 |
Pretax Income | -116.99 | -46.95 | -48.68 | 6.05 | -170.96 | 11.2 |
Income Tax Expense | -4.96 | -0.1 | 1.92 | -0.1 | 1.17 | 23.53 |
Earnings From Continuing Operations | -112.03 | -46.85 | -50.6 | 6.15 | -172.13 | -12.32 |
Net Income to Company | -112.03 | -46.85 | -50.6 | 6.15 | -172.13 | -12.32 |
Minority Interest in Earnings | 12.93 | 0.17 | 4.25 | 1.32 | 48.81 | 14.68 |
Net Income | -99.11 | -46.68 | -46.36 | 7.47 | -123.32 | 2.36 |
Net Income to Common | -99.11 | -46.68 | -46.36 | 7.47 | -123.32 | 2.36 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 104 | 101 | 101 | 101 | 101 | 101 |
Shares Outstanding (Diluted) | 104 | 101 | 101 | 101 | 101 | 101 |
Shares Change | 2.77% | - | - | - | - | - |
EPS (Basic) | -0.96 | -0.46 | -0.46 | 0.07 | -1.22 | 0.02 |
EPS (Diluted) | -0.96 | -0.46 | -0.46 | 0.07 | -1.22 | 0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -56.65 | -39.05 | -46.7 | -71.96 | -136.6 |
Free Cash Flow Per Share | - | -0.56 | -0.39 | -0.46 | -0.71 | -1.35 |
Gross Margin | 21.26% | 36.41% | 44.16% | 43.61% | 43.11% | 46.47% |
Operating Margin | -101.08% | -39.82% | -12.53% | -23.53% | -37.72% | -37.17% |
Profit Margin | -115.91% | -33.55% | -25.01% | 4.02% | -64.40% | 1.13% |
Free Cash Flow Margin | - | -40.72% | -21.07% | -25.12% | -37.58% | -65.16% |
EBITDA | -79.43 | -48.31 | -15.2 | -33.22 | -50.07 | -60.68 |
EBITDA Margin | -92.90% | -34.73% | -8.20% | -17.87% | -26.15% | -28.95% |
D&A For EBITDA | 6.99 | 7.09 | 8.02 | 10.52 | 22.17 | 17.25 |
EBIT | -86.42 | -55.4 | -23.23 | -43.74 | -72.24 | -77.93 |
EBIT Margin | -101.08% | -39.82% | -12.53% | -23.53% | -37.72% | -37.17% |
Effective Tax Rate | - | - | - | - | - | 210.00% |